“…Thus, GET73 affects both hippocampal glutamate and GABA levels without interfering with local aminoacid neurotransmitter reuptake mechanisms. Furthermore, neither selective intrahippocampal CA1 GABA A nor GABA B receptor blockade—with bicuculline and CGP35348, respectively—alters the GET73 (10 mg/kg)‐induced increase in local GABA release—ruling out the possibility a local GET73‐induced GABA A and/or GABA B receptor‐mediate increase in GABA levels (Cobb et al, ; Davies et al, ; Mizoguchi et al, ). The present findings, at least in part, support recent in vitro rat binding studies reporting that GET73 fails to display affinity for a series of alternative receptor targets, including the dopamine (D 1 , D 2 , D 3 ), serotonin (5‐HT 1 , 5‐HT 2 , 5‐HT 3 ), GABA A , GABA B , or ionotropic glutamate (NMDA, AMPA, or kainate) receptor (Loche et al, ).…”